MedTrace Logo

THE EFFECTS OF HPV VACCİNATİON AND MESSAGE FRAMİNG

NCT07614009 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 177

Last updated 2026-05-29

No results posted yet for this study

Summary

Background: University students are at high risk for HPV infection, while HPV vaccination rates remain low. Message framing strategies may influence vaccination-related perceptions and intentions.

Objective: This study aims to compare the effects of gain- and loss-framed HPV vaccination messages on HPV risk perception, HPV knowledge, and vaccination intention among university students.

Methods: This randomized controlled experimental study includes university students from the health sciences faculty of a foundation university. Participants are assigned to gain-framed, loss-framed, and control groups. Data are collected using the Human Papillomavirus Knowledge Scale and the HPV Risk Perception Questionnaire. Statistical analyses include one-way ANOVA, two-way ANOVA, and Chi-square tests. The study is designed in accordance with CONSORT 2010 and EQUATOR Network reporting guidelines.

Keywords: message framing; gain-loss framing; human papillomavirus; vaccination

Conditions

  • Human Papillomavirus (HPV) Vaccination
  • Message Framing
  • Vaccination Intention

Interventions

BEHAVIORAL

Gain-Framed HPV Vaccination Message

Participants received gain-framed messages emphasizing the benefits of HPV vaccination.

BEHAVIORAL

Loss-Framed HPV Vaccination Message

Participants received loss-framed messages emphasizing the consequences of not receiving HPV vaccination.

Sponsors & Collaborators

  • Ankara Medipol University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-16
Primary Completion
2026-01-25
Completion
2026-01-25

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07614009 on ClinicalTrials.gov